Crosstalk between CYP2E1 and PPAR

CYP2E1 FGF21 Metabolic enzyme Nuclear receptor Obesity PPARα

Journal

Acta pharmaceutica Sinica. B
ISSN: 2211-3835
Titre abrégé: Acta Pharm Sin B
Pays: Netherlands
ID NLM: 101600560

Informations de publication

Date de publication:
May 2022
Historique:
received: 18 11 2021
revised: 11 01 2022
accepted: 28 01 2022
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 2 6 2022
Statut: ppublish

Résumé

Although the functions of metabolic enzymes and nuclear receptors in controlling physiological homeostasis have been established, their crosstalk in modulating metabolic disease has not been explored. Genetic ablation of the xenobiotic-metabolizing cytochrome P450 enzyme CYP2E1 in mice markedly induced adipose browning and increased energy expenditure to improve obesity. CYP2E1 deficiency activated the expression of hepatic peroxisome proliferator-activated receptor alpha (PPAR

Identifiants

pubmed: 35646522
doi: 10.1016/j.apsb.2022.02.004
pii: S2211-3835(22)00054-5
pmc: PMC9136617
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2224-2238

Informations de copyright

© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

Références

Cell Rep. 2018 Jul 24;24(4):809-814
pubmed: 30044978
Clin Pharmacokinet. 2016 Jul;55(7):833-847
pubmed: 26818482
FASEB J. 2012 Feb;26(2):628-38
pubmed: 22009939
Endocr Rev. 2018 Oct 1;39(5):760-802
pubmed: 30020428
J Biol Chem. 1993 Jun 15;268(17):12912-8
pubmed: 8509425
Arch Pharm Res. 2016 Sep;39(9):1232-6
pubmed: 27384065
J Nutr. 1991 Jul;121(7):959-65
pubmed: 2051238
Toxicology. 2017 Apr 15;381:10-18
pubmed: 28232125
Biochem Biophys Res Commun. 2007 Aug 24;360(2):437-40
pubmed: 17601491
J Biol Chem. 2005 May 13;280(19):18667-82
pubmed: 15774422
Drug Metab Rev. 2019 May;51(2):178-195
pubmed: 31203697
Am J Physiol Endocrinol Metab. 2017 Jun 1;312(6):E508-E518
pubmed: 28223294
Nat Med. 2017 Nov;23(11):1298-1308
pubmed: 29035368
Biochem J. 2005 Sep 15;390(Pt 3):719-27
pubmed: 15916533
J Biochem. 1994 Feb;115(2):338-44
pubmed: 8206883
J Clin Lab Anal. 1997;11(5):287-313
pubmed: 9292395
J Biol Chem. 1996 May 17;271(20):12063-7
pubmed: 8662637
Free Radic Biol Med. 2008 Mar 1;44(5):723-38
pubmed: 18078827
Drug Metab Dispos. 2016 May;44(5):720-31
pubmed: 26965985
Obes Rev. 2017 Aug;18(8):819-831
pubmed: 28547916
Drug Metab Dispos. 2010 Dec;38(12):2286-92
pubmed: 20826547
Nat Rev Drug Discov. 2004 Aug;3(8):695-710
pubmed: 15286736
Biochimie. 2017 May;136:100-104
pubmed: 27916640
J Hepatol. 2012 Oct;57(4):860-6
pubmed: 22668639
Chem Res Toxicol. 2009 Apr;22(4):699-707
pubmed: 19256530
J Biol Chem. 2010 Jul 16;285(29):22282-90
pubmed: 20463018
Nat Rev Endocrinol. 2020 Nov;16(11):654-667
pubmed: 32764725
Cell Metab. 2013 Sep 3;18(3):333-40
pubmed: 24011069
Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G283-G299
pubmed: 28082284
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312-7
pubmed: 9113986
Nat Commun. 2015 Dec 15;6:10166
pubmed: 26670557
Br J Clin Pharmacol. 2003 Jan;55(1):77-85
pubmed: 12534643
Am J Physiol Endocrinol Metab. 2012 Mar 1;302(5):E532-9
pubmed: 22185839
Acta Pharm Sin B. 2020 Jan;10(1):3-18
pubmed: 31993304
Food Sci Nutr. 2021 Aug 11;9(10):5854-5868
pubmed: 34646551
ACS Chem Biol. 2016 Sep 16;11(9):2447-55
pubmed: 27337155
Toxicol Lett. 2001 Dec 15;125(1-3):83-91
pubmed: 11701226
Nat Rev Endocrinol. 2019 May;15(5):288-298
pubmed: 30814686
Biochem Pharmacol. 1965 Apr;14:393-410
pubmed: 14322966
J Clin Invest. 2014 Sep;124(9):3913-22
pubmed: 25133427
Clin Pharmacol Ther. 1994 Oct;56(4):359-67
pubmed: 7955797
J Biol Chem. 2008 Nov 28;283(48):33698-707
pubmed: 18818195
Nat Rev Endocrinol. 2020 Jul;16(7):363-377
pubmed: 32303708
Food Chem. 2015 Jul 15;179:305-10
pubmed: 25722169
Biology (Basel). 2020 Nov 26;9(12):
pubmed: 33255949
Cell Metab. 2017 Oct 3;26(4):672-685.e4
pubmed: 28918936
Xenobiotica. 2021 Sep;51(9):1047-1059
pubmed: 34319859
Int J Mol Sci. 2020 Aug 28;21(17):
pubmed: 32872317
Cell Metab. 2019 Feb 5;29(2):246-253
pubmed: 30726758
J Clin Invest. 2016 May 2;126(5):1704-16
pubmed: 27018708
Cell Metab. 2020 Aug 4;32(2):203-214.e4
pubmed: 32413333
Nat Rev Endocrinol. 2018 Feb;14(2):77-87
pubmed: 29052591
J Biol Chem. 2017 Jun 2;292(22):9175-9190
pubmed: 28404815
Genes Dev. 2012 Feb 1;26(3):271-81
pubmed: 22302939

Auteurs

Youbo Zhang (Y)

State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Tingting Yan (T)

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Tianxia Wang (T)

State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
School of Life Science and Engineering, Lanzhou University of Technology, Lanzhou 730050, China.

Xiaoyan Liu (X)

State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Keisuke Hamada (K)

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Dongxue Sun (D)

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Yizheng Sun (Y)

State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Yanfang Yang (Y)

State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Jing Wang (J)

State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Shogo Takahashi (S)

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Qiong Wang (Q)

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Kristopher W Krausz (KW)

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Changtao Jiang (C)

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, the Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing 100191, China.

Cen Xie (C)

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Xiuwei Yang (X)

State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Frank J Gonzalez (FJ)

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Classifications MeSH